Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients

BACKGROUND: Lung adenocarcinoma (LUAD) is an extraordinarily malignant tumor, with rapidly increasing morbidity and poor prognosis. Immunotherapy has emerged as a hopeful therapeutic modality for lung adenocarcinoma. Furthermore, a prognostic model (based on immune genes) can fulfill the purpose of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Qianhe, Li, Qifan, Shao, Chenye, Zhang, Pengpeng, Hu, Zhuangzhuang, Li, Jun, Wang, Wei, Yu, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517491/
https://www.ncbi.nlm.nih.gov/pubmed/37741993
http://dx.doi.org/10.1186/s12885-023-11249-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517491/
https://www.ncbi.nlm.nih.gov/pubmed/37741993
http://dx.doi.org/10.1186/s12885-023-11249-8

Ejemplares similares